To offer personalized therapies, diagnostics must keep pace to provide the necessary information. Oncobit is a MedTech spin-off from the University of Zurich, developing critical precision diagnostic and monitoring solutions to enable the cancer treatment of the future. A unique combination of technical know-how, proprietary software and close clinical collaborations, allows us to bring more comprehensive and more sensitive tests to the clinic to improve patient care and outcome. With an initial focus on melanoma, our approach is easily expandable to other cancer types in the future. We are collaborating with leading cancer center in Europe and the US to achieve broad acceptance by the medical community.
Location: Switzerland, Zurich, Schlieren
Total raised: $4.19M
Investors 2
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
| - | VentureLab | venturelab... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.11.2024 | Seed | $1.66M | - |
| 30.04.2021 | Seed | $2.53M | - |
Mentions in press and media 20
| Date | Title | Description |
| 22.11.2024 | Oncobit secures CHF 1.47M in Pre-Series A Round to advance precision cancer solutions | Venturelab alumnus Oncobit, a Swiss company specializing in cancer precision medicine, has announced the completion of a Pre-Series A financing round, securing CHF 1.47 million. The round saw participation from existing and new investors, r... |
| 21.11.2024 | CHF 1.5 million pre-series A funding for Oncobit | Incorporated in 2018, Oncobit has developed a scalable and data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers in liquid biopsies. By focusing on specific cancer markers that are most ... |
| 06.09.2024 | Kickfund invests at full throttle | Kickfund Ventures Fund I is a new investment fund dedicated to enhancing Switzerland's innovation ecosystem by supporting deep tech startups have successfully participated in the Venture Kick competition. With an initial closing of CHF 70 ... |
| 05.09.2024 | SwissEF UpScaler supports 14 growth startups | The SwissEF UpScaler Program is a comprehensive growth initiative designed to propel Swiss startups and innovative SMEs into international markets. For 2 years, participants receive a CHF 80,000 voucher for targeted workshops, access to a ... |
| 18.06.2024 | European approval for Oncobit’s cancer marker tests | Oncobit's proprietary melanoma marker test Oncobit PM is designed to detect specific cancer markers in the tumor-derived fraction of circulating cell-free DNA (ctDNA) isolated from the blood of melanoma patients. The tests detect specific ... |
| 01.03.2024 | Oncobit joins forces with Immunocore | Oncobit is a medtech spin-off from the University Hospital of Zurich, that has developed a scalable and data-driven cancer monitoring platform based on a unique combination of proprietary digital PCR assays and software. Its products aim to... |
| 04.10.2023 | Schweizer Cleantech-Lösungen heimsen Preise ein | |
| 20.02.2023 | Swiss startups accelerate precision medicine and value-based healthcare | |
| 28.11.2022 | Experienced managers and researchers join start-ups | |
| 26.08.2022 | Strong Swiss delegation at Medica |
Show more